Dr. Rinka Pahwani, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,533 | 140 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $325.08 | 20 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $292.04 | 9 | $0 (2024) |
| Novo Nordisk Inc | $285.92 | 20 | $0 (2024) |
| Amgen Inc. | $194.70 | 12 | $0 (2024) |
| ABBVIE INC. | $178.29 | 9 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $146.21 | 7 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $120.59 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $101.08 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $92.24 | 6 | $0 (2024) |
| Astellas Pharma US Inc | $90.19 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,059 | 53 | Boehringer Ingelheim Pharmaceuticals, Inc. ($197.73) |
| 2023 | $975.14 | 58 | Lilly USA, LLC ($157.15) |
| 2022 | $498.63 | 29 | Boehringer Ingelheim Pharmaceuticals, Inc. ($75.36) |
All Payment Transactions
140 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/06/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Genetic Disease | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: DIABETES | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Biological | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY, BEXSERO | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: VACCINES | ||||||
| 10/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: PAIN | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Biological | ||||||
| 10/16/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Bone Health | ||||||
| 10/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Cardio-renal | ||||||
| 09/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: DIABETES | ||||||
| 09/20/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Biological | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 09/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $18.14 | General |
| 09/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Bone Health | ||||||
| 08/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Obesity | ||||||
| 08/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Cardio-renal | ||||||
| 08/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: DIABETES | ||||||
| 08/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $9.96 | General |
| Category: Bone Health | ||||||
| 07/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Obesity | ||||||
| 07/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Bone Health | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 636 | 781 | $64,985 | $29,092 |
| 2022 | 12 | 283 | 355 | $39,193 | $15,336 |
| 2021 | 3 | 185 | 221 | $82,540 | $25,227 |
| 2020 | 1 | 81 | 82 | $40,590 | $13,137 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 84 | 127 | $26,035 | $9,567 | 36.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 51 | 51 | $10,914 | $6,229 | 57.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 44 | $7,920 | $2,645 | 33.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 29 | 29 | $2,175 | $2,014 | 92.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $3,520 | $1,720 | 48.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 21 | $3,045 | $1,084 | 35.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 81 | 115 | $1,725 | $966.00 | 56.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 67 | 71 | $2,130 | $931.52 | 43.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 31 | 31 | $1,085 | $904.27 | 83.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 60 | 66 | $1,254 | $683.10 | 54.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 22 | 23 | $1,150 | $667.23 | 58.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 27 | 39 | $1,365 | $641.94 | 47.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 35 | 46 | $966.00 | $437.92 | 45.3% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 29 | 32 | $576.00 | $265.28 | 46.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 18 | 19 | $285.00 | $144.59 | 50.7% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 14 | 16 | $240.00 | $101.44 | 42.3% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 20 | 20 | $300.00 | $46.40 | 15.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 20 | $300.00 | $44.00 | 14.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 66 | $13,440 | $6,044 | 45.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 44 | $6,310 | $2,925 | 46.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 29 | 47 | $8,460 | $2,599 | 30.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 17 | 17 | $4,505 | $1,380 | 30.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 15 | 34 | $3,400 | $1,023 | 30.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 11 | $385.00 | $308.44 | 80.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 25 | 27 | $513.00 | $280.25 | 54.6% |
About Dr. Rinka Pahwani, MD
Dr. Rinka Pahwani, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2017. The National Provider Identifier (NPI) number assigned to this provider is 1790201770.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rinka Pahwani, MD has received a total of $2,533 in payments from pharmaceutical and medical device companies, with $1,059 received in 2024. These payments were reported across 140 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($2,533).
As a Medicare-enrolled provider, Pahwani has provided services to 1,185 Medicare beneficiaries, totaling 1,439 services with total Medicare billing of $82,792. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine
- Location Greensboro, NC
- Active Since 08/21/2017
- Last Updated 02/17/2022
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1790201770
Products in Payments
- JARDIANCE (Drug) $317.32
- EVENITY (Biological) $176.81
- MOUNJARO (Drug) $172.60
- NUZYRA (Drug) $146.21
- Kerendia (Drug) $120.59
- Wegovy (Drug) $106.42
- NURTEC ODT (Drug) $104.64
- Veozah (Drug) $90.19
- QULIPTA (Drug) $87.97
- Ozempic (Drug) $84.84
- Zio monitor (Device) $75.06
- VRAYLAR (Drug) $70.71
- SHINGRIX (Biological) $70.39
- QUVIVIQ (Drug) $56.84
- GVOKE HYPOPEN (Drug) $56.48
- AIRSUPRA (Drug) $49.03
- ACCRUFER (Drug) $46.37
- Rybelsus (Drug) $45.44
- EMGALITY (Drug) $41.13
- NEXLETOL (Drug) $38.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Greensboro
Peter Arnold, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $223,872
Dr. Christopher White, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $13,427
Jon Mugweru, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $7,923
Eugene Bell, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $5,328
Dr. Matthew Gay, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $5,240
Stephanie Wolfe, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $4,597